CyberKnife Radiosurgery for Prostate Cancer
CyberKnife Radiosurgery for Prostate Cancer
复制标题
DOI：
10.1177/153303461000900504
复制
发表时间：
2010-10-01
影响因子：
2.8
通讯作者：
Katz, Alan J.
中科院分区：
文献类型：
--
作者：
Katz, Alan J.
尽管放射生物学数据强烈表明前列腺是一个极好的SBRT靶点，但SBRT治疗前列腺癌对放射肿瘤学界的许多人来说是一个有重大争议的领域。最近，新的数据显示，CyberKnife SBRT治疗前列腺癌的结果很有希望，毒性最小。在下文中，我们介绍了前列腺癌SBRT的动机因素，随后对当前文献进行了批判性评价，并讨论了SBRT治疗前列腺癌的未来。
Treatment of prostate cancer with SBRT is an area of significant controversy for many in the radiation oncology community despite radiobiologic data that strongly suggest the prostate would be an excellent SBRT target. Recently, new data have emerged that show promising outcomes with minimal toxicity for CyberKnife SBRT of prostate cancer. In the following we present the motivating factors for prostate cancer SBRT followed by a critical evaluation of the current literature and discussion of the future of prostate cancer treatment with SBRT.